Company ProfilePremium

Emerald Health Therapeutics, Inc.

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Emerald Health Therapeutics, Inc. - Healthcare showcase

Year Founded & Workforce

2007

200 Employees

Industry

Healthcare

Services

Medical Cannabis
E

Emerald Health Therapeutics, Inc. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Emerald Health Therapeutics, Inc. Overview

Company Headquarter: Vancouver, Canada

Founded: 2007

Workforce: ~200

Company Working: Emerald Health Therapeutics, Inc. is a cannabis company that manufactures medical and wellness-oriented cannabis products. Its team of research scientists is ceaselessly working to develop new product lines with improved reproducibility and consistency. Its products involve smoke-free cannabis products, whole-flower cannabis, and medical cannabis. The company operates through numerous subsidiaries such as Verdelite Sciences, Inc. (Canada), Northern Vine Canada Inc. (Canada), and Verdelite Property Holdings, Inc. (Canada). Verdelite Property Holdings, Inc. has over 60 years of industry experience in cannabis cultivation. It cultivates, harvests, dries, extracts, packs, and ships cannabis. Moreover, Emerald Health Therapeutics, Inc. is a licensed producer and distributor of medical cannabis products, including cannabis oil and capsules. In November 2022, Emerald Health Therapeutics, Inc. became a subsidiary of Skye Bioscience, Inc. (US) to boost the product sales of Emerald.

Strategy

Emerald Health Therapeutics, Inc. consistently develops and attracts new technologies to help advance the company’s innovation and growth strategies. The company is collaborating with new providers and companies to provide services and bring technologies to amplify the benefits of its core products. Additionally, it focuses on transparency and sustainability in the entire manufacturing process, from the plant to the end product.

Company Snapshot

200

Employees

2007

Founded

SWOT Analysis

Strengths

  • Strong presence in the US and Canada
  • High-quality products
  • Strong customer support

Weaknesses

  • Limited workforce
  • Limited penetration in developing market

Opportunities

  • Raising investment to sell cannabis natural products
  • Increasing the use of online platforms

Threats

  • Price fluctuations
  • Changing political landscape

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
March 2021PartnershipEmerald Health Therapeutics, Inc. partnered with Medical Plants SLU, based in Almeria, Spain, in which it will provide resources and expertise to assist Medical Plants. This acquired boosted the production of medical cannabis dried flower and 2.0 products to serve emerging legal medical cannabis markets in the European Union (EU) and other countries that require high-grade GMP-certified flower or derivatives.
January 2019Joint VentureEmerald Health Therapeutics, Inc. closed its 51:49 joint venture with San Diego-based Emerald Health Bioceuticals, called Emerald Health Naturals (US). This joint venture assist company to build its health brand through Emerald Health Naturals and start sales of endocannabinoid-supporting products in natural health product channels.
July 2018AcquisitionEmerald Health Therapeutics, Inc. acquired the remaining shares of Northern Vine Canada Inc. (Canada), owned by Abattis Bioceuticals Corp (Canada). The acquired assist the company to leverage its dealer license and R&D facility; which further help advance its research plans to develop cannabis formulations, supporting new products for recreational purposes and treat a broad spectrum of human conditions and diseases.

Product Offering

  • Emerald Health Therapeutics, Inc.
    • Medical Cannabis

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.